E
Elena G. Tikhomolova
Publications - 2
Citations - 239
Elena G. Tikhomolova is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Clinical trial. The author has an hindex of 2, co-authored 2 publications receiving 116 citations.
Papers
More filters
Journal ArticleDOI
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
Andrey Alexandrovich Ivashchenko,Kirill A. Dmitriev,Natalia V. Vostokova,Valeria N Azarova,Andrew A. Blinow,Alina N. Egorova,Ivan G. Gordeev,Alexey P. Ilin,Ruben N. Karapetian,Dmitry V. Kravchenko,Nikita V. Lomakin,Elena A. Merkulova,Natalia A. Papazova,Elena P. Pavlikova,Nikolay Filippovich Savchuk,Elena N Simakina,Tagir A. Sitdekov,Elena A Smolyarchuk,Elena G. Tikhomolova,Elena V Yakubova,Alexandre V. Ivachtchenko +20 more
TL;DR: In the pilot stage of Phase II/III clinical trial, AVIFAVIR enabled SARS-CoV-2 viral clearance in 62.5% of patients within 4 days, and was safe and well-tolerated.
Posted ContentDOI
AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
Andrey Alexandrovich Ivashchenko,Kirill A. Dmitriev,Natalia V. Vostokova,Valeria N Azarova,Andrew A. Blinow,Alina N. Egorova,Ivan G. Gordeev,Alexey P. Ilin,Ruben N. Karapetian,Dmitry V. Kravchenko,Nikita V. Lomakin,Elena A. Merkulova,Natalia A. Papazova,Elena P. Pavlikova,Nikolay Filippovich Savchuk,Elena N Simakina,Tagir A. Sitdekov,Elena A Smolyarchuk,Elena G. Tikhomolova,Elena V Yakubova,Alexandre V. Ivachtchenko +20 more
TL;DR: In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients.